Reuters logo
BRIEF-VBL THERAPEUTICS OPENS NEW GENE THERAPY MANUFACTURING PLANT, HEADQUARTERS
2017年10月23日 / 中午12点18分 / 1 个月前

BRIEF-VBL THERAPEUTICS OPENS NEW GENE THERAPY MANUFACTURING PLANT, HEADQUARTERS

Oct 23 (Reuters) - Vascular Biogenics Ltd:

* VBL THERAPEUTICS CELEBRATES OPENING OF ITS NEW GENE THERAPY MANUFACTURING PLANT AND COMPANY HEADQUARTERS

* PLANT IN MODIIN, ISRAEL WILL BE COMMERCIAL FACILITY FOR PRODUCTION OF OFRANERGENE OBADENOVEC (VB-111), IF APPROVED​

* ‍VBL EXPECTS THAT CURRENT CASH WILL FUND COMPANY‘S OPERATING EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO 2019​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below